Anemia Among Hospitalized Children in a Ghanaian Pediatric Emergency Unit: A Prospective Observational Study of

Serwah Bonsu Asafo-Agyei1,2, Emmanuel Ameyaw1,2, Samuel Blay Nguah1,2

  • 1School of Medical Sciences Kwame Nkrumah University of Science and Technology Kumasi Ghana.

Insights

Anemia is highly prevalent in Ghanaian pediatric emergency units, affecting two-thirds of children. Severe anemia, often linked to iron deficiency, sickle cell disease, and malaria, frequently requires blood transfusions.

Area of Science:

  • Pediatric Emergency Medicine
  • Hematology
  • Global Health

Background:

  • Anemia is a significant cause of child illness and death in sub-Saharan Africa.
  • Data on anemia in pediatric emergency settings, especially for older children, are scarce.
  • This study addresses the knowledge gap in Ghana.

Purpose of the Study:

  • To determine the prevalence and factors associated with anemia in children admitted to a pediatric emergency unit in Ghana.
  • To describe the hematological characteristics and clinical outcomes of anemic children.
  • To inform targeted interventions for anemia in this population.

Main Methods:

  • Prospective observational study of 318 children (2 months to 17 years) admitted to a pediatric emergency unit in Kumasi, Ghana.
  • Data collected via caregiver interviews and medical records.
  • Anemia defined by WHO criteria; logistic regression used to identify associated factors.

Main Results:

  • Anemia prevalence was 66.7% among admitted children.
  • Moderate anemia was most common, but severe anemia was more frequent in older children.
  • Microcytic anemia, suggestive of iron deficiency, was prevalent and associated with sickle cell disease and malaria.

Conclusions:

  • Anemia is highly prevalent and severe in Ghanaian pediatric emergency settings, often necessitating blood transfusions.
  • Interventions should focus on early detection of hemoglobinopathies, malaria control, and nutritional support.
  • Strengthened strategies are needed in pediatric emergency and inpatient care.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...